Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar;86(3):256-308.
doi: 10.1016/j.jinf.2023.01.006. Epub 2023 Jan 9.

The risk of methicillin-resistant Staphylococcus aureus infection following COVID-19 and influenza: A retrospective cohort study from the TriNetX network

Ya-Wen Tsai  1 , Chia-Fen Tsai  2 , Jheng-Yan Wu  3 , Po-Yu Huang  4 , Ting-Hui Liu  5 , Chih-Cheng Lai  6
Affiliations
Comment

The risk of methicillin-resistant Staphylococcus aureus infection following COVID-19 and influenza: A retrospective cohort study from the TriNetX network

Ya-Wen Tsai et al. J Infect. 2023 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig 1
Fig. 1
The incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in COVID-19 and influenza cohorts.
See this image and copyright information in PMC

Comment on

References

    1. Youngs J., Wyncoll D., Hopkins P., Arnold A., Ball J., Bicanic T. Improving antibiotic stewardship in COVID-19: bacterial co-infection is less common than with influenza. J Infect. 2020;81(3):e55. -e7. - PMC - PubMed
    1. Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275. - PMC - PubMed
    1. Murgia F., Fiamma M., Serra S., Olla S., Garau M.C., Cocco E., et al. The impact of secondary infections in COVID-19 critically ill patients. J Infect. 2022;84(6):e116. -e7. - PMC - PubMed
    1. Musuuza J.S., Watson L., Parmasad V., Putman-Buehler N., Christensen L., Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS One. 2021;16(5) - PMC - PubMed
    1. Lai C.C., Wang C.Y., Hsueh P.R. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53(4):505–512. - PMC - PubMed

MeSH terms

Substances